A Certified Podcast Series

Managing Classical Hodgkin Lymphoma With Antibody-Drug Conjugates
Release Date: Thursday, February 28, 2019
Expire Date: Friday, February 28, 2020


Anticipating and Managing Side Effects for Patients With Classical Hodgkin Lymphoma

Amy Goodrich, RN, MSN, CRNP-AC, and Barbara Rogers, CRNP, MN, AOCN®, ANP-BC, review best practices for anticipating and managing side effects for patients being treated for classical Hodgkin lymphoma, including the short- and long-term adverse events associated with chemotherapy, checkpoint inhibitors, and antibody–drug conjugates.

Estimated Time to Complete: 30 minutes
Review CME Information and Access Pre-Test



Shared Decision-Making: How to Discuss Therapeutic Options With Your Patients Considering Treatment for Classical Hodgkin Lymphoma

Amy Goodrich, RN, MSN, CRNP-AC, and Kevin Nguyen, a patient who was treated for classical Hodgkin lymphoma, discuss his treatment journey from diagnosis through relapse and how shared decision-making between him and his health-care team played an important role in the process.

Estimated Time to Complete: 30 minutes
Review CME Information and Access Pre-Test



Role of Antibody-Drug Conjugates for Front-Line Therapy in Classical Hodgkin Lymphoma

Amy Goodrich, RN, MSN, CRNP-AC, and Nadia Khan, MD, discuss the role of antibody-drug conjugates in the treatment of classical Hodgkin lymphoma, including mechanism of action, recent approvals, emerging data, and expert guidance on clinical application.

Estimated Time to Complete: 30 minutes
Review CME Information and Access Pre-Test



These activities, certified for CME/CE/CPE credit, are jointly provided by

Copyright © 2010-2019 Harborside Press, LLC All rights reserved.               
Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact | Copyright Notice/Disclaimer | Subscribe
Bot trap - Don't go here
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.